Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Pearlman Bruce Allen"'
Autor:
Lai Chan, Mark A. Lyster, Meredith L. Greene, Paul M. Herrinton, Pearlman Bruce Allen, Barbachyn Michael R, Jiong J. Chen, Robert C. Gadwood, Jeffery A. Moeslein, William R. Perrault, Cuong V. Lu, Koji Yamagata, Mark T. Maloney, Azhwarsamy Jeganathan, Godrej Delara B
Publikováno v:
Organic Process Research & Development. 7:533-546
Since 1993, a significant process research and development effort directed towards the large-scale synthesis of oxazolidinone antibacterial agents has been ongoing in both Early Chemical Process Research and Development, and Chemical Process Research
Autor:
Moses W. McMillan, Perrault William R, William Watt,§ and, Donald J. Knoechel, Lori A. LaPean, Mark A. Krook, Gerald N. Evenson, Pearlman Bruce Allen, Mark A. Lyster, K. Paul Shephard, Paul J. Dobrowolski
Publikováno v:
Organic Process Research & Development. 1:106-116
A practical synthesis of atevirdine mesylate, Pharmacia & Upjohn's first-generation non-nucleoside reverse transcriptase (RT) inhibitor for treatment of AIDS, is described. The route consists of three steps. In the first step, the starting material,
Autor:
Christian L. Clark, Richard J. Imbordino, William R. Perrault, William C. Snyder, Pearlman Bruce Allen, James B. Keeler, Stephen L. Secreast, Rebecca M. Anderson, Nabil Ghazal, Michael R. Reeder
Pfizer has developed a novel, convergent, green synthesis of linezolid (the active ingredient in Zyvox TM ). The second-generation process has replaced the launch process and has numerous green chemistry benefits. Chlorohydrin imine reagent 1 contain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c041a7cdf3d6304a88b800f453e860bc
https://doi.org/10.1201/b15466-11
https://doi.org/10.1201/b15466-11